Leaflet CANDESARTAN HCT TCHAIKAPHARMA 8mg / 12.5mg tablets


Indicated for: hypertension

Route of administration: oral

Substance: candesartan cilexetil + hydrochlorothiazide (antihypertensive + diuretic)

ATC: C09DA06 (Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics)

Precautions:
Dose adjustment in renal impairment
Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Photosensitivity
Photosensitivity

Avoid excessive exposure to sunlight or UV radiation.

Hypotension / fall risk
Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Electrolyte disturbances
Electrolyte disturbances

This medicine may change blood electrolyte levels.

Candesartan cilexetil and hydrochlorothiazide are used together for the treatment of high blood pressure, especially in patients who do not respond adequately to monotherapy. This combination combines an angiotensin II receptor antagonist (candesartan) and a thiazide diuretic (hydrochlorothiazide).

Candesartan helps relax blood vessels, while hydrochlorothiazide increases the elimination of excess water and salt through urine, thereby reducing blood volume and blood pressure.

The medication is taken orally, usually once daily, as directed by a doctor. It is important to monitor blood pressure and electrolyte levels during treatment.

Side effects may include dizziness, fatigue, electrolyte imbalances, or, in rare cases, allergic reactions. Patients should inform their doctor of any unusual symptoms.

General data about CANDESARTAN HCT TCHAIKAPHARMA 8mg / 12.5mg

  • Substance: candesartan cilexetil + hydrochlorothiazide
  • Date of last drug list: 01-10-2015
  • Commercial code: W61983001
  • Concentration: 8mg / 12.5mg
  • Pharmaceutical form: tablets
  • Quantity: 30
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Concentrations available for candesartan cilexetil + hydrochlorothiazide

  • 16mg/12.5mg
  • 32mg/12.5mg
  • 32mg/25mg
  • 8mg/12.5mg